VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,926,909 | -30.9% | 1,176,426 | -23.4% | 0.01% | -28.6% |
| Q2 2023 | $46,217,064 | +41.2% | 1,535,130 | +50.9% | 0.01% | +27.3% |
| Q1 2023 | $32,735,176 | -6.9% | 1,017,097 | -16.6% | 0.01% | -8.3% |
| Q4 2022 | $35,177,000 | +42.1% | 1,219,245 | +18.8% | 0.01% | +33.3% |
| Q3 2022 | $24,749,000 | -20.8% | 1,026,658 | -10.2% | 0.01% | -18.2% |
| Q2 2022 | $31,233,000 | -18.1% | 1,142,939 | +15.0% | 0.01% | 0.0% |
| Q1 2022 | $38,146,000 | +90.6% | 994,044 | +59.1% | 0.01% | +83.3% |
| Q4 2021 | $20,011,000 | -10.4% | 624,729 | -17.5% | 0.01% | -14.3% |
| Q3 2021 | $22,323,000 | -28.9% | 756,847 | -18.3% | 0.01% | -30.0% |
| Q2 2021 | $31,393,000 | -29.7% | 926,851 | -32.3% | 0.01% | -33.3% |
| Q1 2021 | $44,634,000 | -17.0% | 1,368,223 | -8.0% | 0.02% | -21.1% |
| Q4 2020 | $53,767,000 | +16.9% | 1,486,785 | +26.6% | 0.02% | 0.0% |
| Q3 2020 | $46,002,000 | +13.0% | 1,174,660 | +5.6% | 0.02% | +11.8% |
| Q2 2020 | $40,692,000 | +299.4% | 1,112,643 | +151.7% | 0.02% | +240.0% |
| Q1 2020 | $10,188,000 | -60.0% | 442,124 | -49.2% | 0.01% | -54.5% |
| Q4 2019 | $25,501,000 | +12.3% | 869,906 | +2.7% | 0.01% | +10.0% |
| Q3 2019 | $22,703,000 | -6.9% | 846,898 | -11.2% | 0.01% | -9.1% |
| Q2 2019 | $24,376,000 | +17.8% | 953,729 | +0.7% | 0.01% | +10.0% |
| Q1 2019 | $20,688,000 | +29.6% | 947,243 | +25.0% | 0.01% | +25.0% |
| Q4 2018 | $15,969,000 | -48.6% | 757,728 | +11.4% | 0.01% | -27.3% |
| Q3 2018 | $31,077,000 | +96.0% | 680,149 | -4.5% | 0.01% | +57.1% |
| Q2 2018 | $15,859,000 | -1.1% | 712,239 | -2.3% | 0.01% | 0.0% |
| Q1 2018 | $16,031,000 | -16.4% | 729,346 | -11.7% | 0.01% | -22.2% |
| Q4 2017 | $19,172,000 | +51.1% | 826,054 | +49.3% | 0.01% | +50.0% |
| Q3 2017 | $12,689,000 | -5.3% | 553,321 | -14.4% | 0.01% | -14.3% |
| Q2 2017 | $13,393,000 | +3.3% | 646,191 | +13.6% | 0.01% | 0.0% |
| Q1 2017 | $12,969,000 | +57.0% | 568,656 | +44.0% | 0.01% | +40.0% |
| Q4 2016 | $8,259,000 | +20.9% | 395,002 | +52.8% | 0.01% | +25.0% |
| Q3 2016 | $6,830,000 | -4.8% | 258,432 | -0.2% | 0.00% | 0.0% |
| Q2 2016 | $7,175,000 | – | 259,032 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |